1.95
-0.13 (-6.25%)
| Penutupan Terdahulu | 2.08 |
| Buka | 2.09 |
| Jumlah Dagangan | 1,190,129 |
| Purata Dagangan (3B) | 946,184 |
| Modal Pasaran | 116,041,616 |
| Harga / Buku (P/B) | 4.61 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 28 Oct 2025 |
| EPS Cair (TTM) | -3.54 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 27.58% |
| Nisbah Semasa (MRQ) | 2.26 |
| Aliran Tunai Operasi (OCF TTM) | -113.53 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -74.11 M |
| Pulangan Atas Aset (ROA TTM) | -74.21% |
| Pulangan Atas Ekuiti (ROE TTM) | -156.81% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Biomea Fusion, Inc. | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 1.63 |
|
Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 9.76% |
| % Dimiliki oleh Institusi | 45.04% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 16.00 (D. Boral Capital, 720.51%) | Beli |
| Median | 8.50 (335.90%) | |
| Rendah | 5.00 (Jefferies, 156.41%) | Beli |
| Purata | 9.50 (387.18%) | |
| Jumlah | 4 Beli | |
| Harga Purata @ Panggilan | 1.80 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| D. Boral Capital | 07 Oct 2025 | 16.00 (720.51%) | Beli | 2.15 |
| 03 Oct 2025 | 16.00 (720.51%) | Beli | 2.15 | |
| Jefferies | 28 Aug 2025 | 5.00 (156.41%) | Beli | 1.92 |
| Citigroup | 11 Aug 2025 | 7.00 (258.97%) | Beli | 1.53 |
| 16 Jul 2025 | 9.00 (361.54%) | Beli | 1.91 | |
| Scotiabank | 06 Aug 2025 | 10.00 (412.82%) | Beli | 1.59 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |